40 related articles for article (PubMed ID: 30543834)
1. A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling.
Lee B; Oh Y; Jo S; Kim TH; Ji JD
Immunol Lett; 2019 Feb; 206():33-40. PubMed ID: 30543834
[TBL] [Abstract][Full Text] [Related]
2. p-Smad3 differentially regulates the cytological behavior of osteoclasts before and after osteoblasts maturation.
Ye J; Hua Z; Xiao J; Shao Y; Li S; Yin H; Wu M; Rong Y; Hong B; Guo Y; Ma Y; Wang J
Mol Biol Rep; 2024 Apr; 51(1):525. PubMed ID: 38632128
[TBL] [Abstract][Full Text] [Related]
3. Periodontal ligament-associated protein-1 knockout mice regulate the differentiation of osteoclasts and osteoblasts through TGF-β1/Smad signaling pathway.
Liu S; Yan X; Guo J; An H; Li X; Yang L; Yu X; Li S
J Cell Physiol; 2024 Mar; 239(3):e31062. PubMed ID: 37357387
[TBL] [Abstract][Full Text] [Related]
4. Study on the interaction protein of transcription factor Smad3 based on TurboID proximity labeling technology.
Yan B; Zeng T; Liu X; Guo Y; Chen H; Guo S; Liu W
Genomics; 2024 May; 116(3):110839. PubMed ID: 38537808
[TBL] [Abstract][Full Text] [Related]
5. Effects of TGF‑β1 on the migration and morphology of RAW264.7 cells in vitro.
Ueta M; Takaoka K; Yamamura M; Maeda H; Tamaoka J; Nakano Y; Noguchi K; Kishimoto H
Mol Med Rep; 2019 Nov; 20(5):4331-4339. PubMed ID: 31545488
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases.
Agidigbi TS; Kim C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336616
[TBL] [Abstract][Full Text] [Related]
7. Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions.
Jann J; Gascon S; Roux S; Faucheux N
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066607
[TBL] [Abstract][Full Text] [Related]
8. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.
Kang H; Jha S; Ivovic A; Fratzl-Zelman N; Deng Z; Mitra A; Cabral WA; Hanson EP; Lange E; Cowen EW; Katz J; Roschger P; Klaushofer K; Dale RK; Siegel RM; Bhattacharyya T; Marini JC
J Exp Med; 2020 May; 217(5):. PubMed ID: 32232430
[TBL] [Abstract][Full Text] [Related]
9. The Inflammatory Contribution of B-Lymphocytes and Neutrophils in Progression to Osteoporosis.
Frase D; Lee C; Nachiappan C; Gupta R; Akkouch A
Cells; 2023 Jun; 12(13):. PubMed ID: 37443778
[TBL] [Abstract][Full Text] [Related]
10. Progress of Wnt Signaling Pathway in Osteoporosis.
Gao Y; Chen N; Fu Z; Zhang Q
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979418
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
[TBL] [Abstract][Full Text] [Related]
12. miRNA-Based Early Healing Mechanism of Extraction Sockets: miR-190a-5p, a Potential Enhancer of Bone Healing.
Lee SK; Jung SH; Song SJ; Lee IG; Choi JY; Zadeh H; Lee DW; Pi SH; You HK
Biomed Res Int; 2022; 2022():7194640. PubMed ID: 36317115
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-mediated immunomodulation of osteoclastogenesis.
Zhou P; Zheng T; Zhao B
Bone; 2022 Nov; 164():116540. PubMed ID: 36031187
[TBL] [Abstract][Full Text] [Related]
14. Interspecies Single-Cell RNA-Seq Analysis Reveals the Novel Trajectory of Osteoclast Differentiation and Therapeutic Targets.
Omata Y; Okada H; Uebe S; Izawa N; Ekici AB; Sarter K; Saito T; Schett G; Tanaka S; Zaiss MM
JBMR Plus; 2022 Jul; 6(7):e10631. PubMed ID: 35866155
[TBL] [Abstract][Full Text] [Related]
15. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.
Xia Y; Inoue K; Du Y; Baker SJ; Reddy EP; Greenblatt MB; Zhao B
Nat Commun; 2022 Jul; 13(1):3920. PubMed ID: 35798734
[TBL] [Abstract][Full Text] [Related]
16. The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.
Wang J; Xiao L; Wang W; Zhang D; Ma Y; Zhang Y; Wang X
Front Bioeng Biotechnol; 2022; 10():837172. PubMed ID: 35646879
[TBL] [Abstract][Full Text] [Related]
17. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
18. Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin.
Tewari D; Priya A; Bishayee A; Bishayee A
Clin Transl Med; 2022 Apr; 12(4):e795. PubMed ID: 35384373
[TBL] [Abstract][Full Text] [Related]
19. The Rising Era of "Immunoporosis": Role of Immune System in the Pathophysiology of Osteoporosis.
Srivastava RK; Sapra L
J Inflamm Res; 2022; 15():1667-1698. PubMed ID: 35282271
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway.
Kim JH; Yang YR; Kwon KS; Kim N
J Bone Metab; 2021 Aug; 28(3):223-230. PubMed ID: 34520656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
